1.Primary Sclerosing Cholangitis.
The Korean Journal of Hepatology 2004;10(2):154-157
No abstract available.
Adult
;
Cholangitis, Sclerosing/*diagnosis/pathology
;
Diagnosis, Differential
;
Humans
;
Liver Cirrhosis, Biliary/diagnosis
;
Male
2.Drug-induced bile duct injury: progress and challenges.
Chinese Journal of Hepatology 2023;31(4):339-344
Drug-induced bile duct injury is a specific kind of drug-induced liver injury that has two main pathological types, namely ductopenia, or vanishing bile duct syndrome, and secondary sclerosing cholangitis. However, in recent years, the reports of new drugs that cause bile duct injury have been constantly increasing, and these drugs have different clinicopathological features and a novel pathogenesis. Therefore, this paper summarizes and analyzes the progress and challenges in the etiology, pathogenesis, diagnosis and treatment, and other aspects of drug-induced bile duct injury.
Humans
;
Cholestasis/chemically induced*
;
Cholangitis, Sclerosing/diagnosis*
;
Chemical and Drug Induced Liver Injury/pathology*
;
Bile Ducts/pathology*
5.Portal inflammation and bile ductular proliferation.
Chinese Journal of Pathology 2006;35(11):695-696
Antigens, CD1
;
metabolism
;
Child, Preschool
;
Cholangitis, Sclerosing
;
diagnosis
;
etiology
;
metabolism
;
Diagnosis, Differential
;
Female
;
Histiocytosis, Langerhans-Cell
;
complications
;
metabolism
;
pathology
;
Humans
;
Immunohistochemistry
;
Liver
;
metabolism
;
pathology
;
S100 Proteins
;
metabolism
6.A Case of Sclerosing Cholangitis Showing Response to Prednisolone.
Yo Sig SHIN ; Yong Seok JANG ; Min Kyoung KANG ; Byoung Kuk JANG ; Kyung Sik PARK ; Jae Seok HWANG ; Jung Hyeok KWON ; Yu Na KANG
The Korean Journal of Gastroenterology 2007;50(6):402-406
Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease characterized by progressive fibrosis and destruction of intra- and extrahepatic bile ducts resulting in hepatic failure and death. Only the liver transplantation is the possible treatment for patients to survive. There has been a few reports that steroid is an effective treatment in autoimmune variant sclerosing cholangitis, which is thought to be a familial diseases with different etiology, and steroid responsive biliary strictures be named as immunoglobulin G4 (IgG4)-associated cholangitis (IAC). There is no reliable data regarding effective steroid treatment in autoimmue variant sclerosing cholangitis in Korea. We report a case of 32-year-old male with sclerosing cholangitis, who was diagnosed by endoscopic retrograde cholangiopancreatography (ERCP) and liver biopsy, showing favorable response to prednisolone therapy.
Adult
;
Anti-Inflammatory Agents/*therapeutic use
;
Cholangiopancreatography, Endoscopic Retrograde/methods
;
Cholangitis, Sclerosing/*diagnosis/pathology
;
Humans
;
Male
;
Prednisolone/*therapeutic use
;
Treatment Outcome
7.Comparison of Clinical Findings between Autoimmune Pancreatitis with Bile Duct Involvement and Primary Sclerosing Cholangitis.
Ja Young KIM ; Myung Hwan KIM ; Ji Hoon JUNG ; Ju Hyung SONG ; Hyoung Chul OH ; Seung Hyun KWON ; Tae Yoon LEE ; Sang Soo LEE ; Dong Wan SEO ; Sung Koo LEE
The Korean Journal of Gastroenterology 2006;48(2):104-111
BACKGOUND/AIMS: The involvement of bile ducts is frequently reported in autoimmune pancreatitis (AIP), which seem to have similar features to primary sclerosing cholangitis (PSC). Recent systematic comparative studies about these diseases are rare in Korea. METHODS: We retrospectively analyzed 26 patients with AIP with bile duct involvement and 30 patients with classic PSC who were diagnosed during the last decade. RESULTS: The mean age of patients was significantly higher in AIP than PSC at the time of diagnosis. There was a preponderance of men in both group, which was more prominent in AIP. The most common symptom in patients with AIP was jaundice, but PSC patients usually visited hospitals due to incidentally detected abnormal liver function tests. Most (26/31) of AIP had bile duct involvement. All of these patients showed narrowing of intrapancreatic common bile ducts and one patient exhibited hilar involvement as well. About 80% of PSC had both intra- and extrahepatic ducts involvement, and the characteristic features involve multifocal strictures. AIP patients showed improvement with steroid treatment, however, most PSC patients showed clinical deterioration. CONCLUSIONS: The clinical and cholangiographic findings of patients with AIP and PSC have many different characteristics. Therefore, further study of two diseases is required for the proper diagnosis and management.
Autoimmune Diseases/*diagnosis/pathology/radiography
;
Bile Ducts/pathology
;
*Cholangiography
;
Cholangiopancreatography, Endoscopic Retrograde
;
Cholangitis, Sclerosing/*diagnosis/pathology/radiography
;
Diagnosis, Differential
;
Female
;
Humans
;
Immunoglobulins/blood
;
Male
;
Pancreatitis/*diagnosis/*immunology/pathology
;
Retrospective Studies
;
Sex Factors
8.Sclerosing Cholangitis: Clinicopathologic Features, Imaging Spectrum, and Systemic Approach to Differential Diagnosis.
Nieun SEO ; So Yeon KIM ; Seung Soo LEE ; Jae Ho BYUN ; Jin Hee KIM ; Hyoung Jung KIM ; Moon Gyu LEE
Korean Journal of Radiology 2016;17(1):25-38
Sclerosing cholangitis is a spectrum of chronic progressive cholestatic liver disease characterized by inflammation, fibrosis, and stricture of the bile ducts, which can be classified as primary and secondary sclerosing cholangitis. Primary sclerosing cholangitis is a chronic progressive liver disease of unknown cause. On the other hand, secondary sclerosing cholangitis has identifiable causes that include immunoglobulin G4-related sclerosing disease, recurrent pyogenic cholangitis, ischemic cholangitis, acquired immunodeficiency syndrome-related cholangitis, and eosinophilic cholangitis. In this review, we suggest a systemic approach to the differential diagnosis of sclerosing cholangitis based on the clinical and laboratory findings, as well as the typical imaging features on computed tomography and magnetic resonance (MR) imaging with MR cholangiography. Familiarity with various etiologies of sclerosing cholangitis and awareness of their typical clinical and imaging findings are essential for an accurate diagnosis and appropriate management.
Adult
;
Aged
;
Aged, 80 and over
;
Bile Ducts/*pathology
;
Cholangiography/*methods
;
Cholangitis/diagnosis/*pathology
;
Cholangitis, Sclerosing/*diagnosis/pathology
;
Cholestasis/diagnosis/*pathology
;
Chronic Disease
;
Constriction, Pathologic/diagnosis
;
Diagnosis, Differential
;
Female
;
Humans
;
Immunoglobulin G/immunology
;
Liver/pathology
;
Magnetic Resonance Imaging/methods
;
Male
;
Middle Aged
;
Tomography, X-Ray Computed/methods
9.Excerpt from the 2022 American Association for the Study of Liver Diseases clinical practice guideline: management of primary sclerosing cholangitis and cholangiocarcinoma.
Chinese Journal of Hepatology 2023;31(1):35-41
What are the new contents of the guideline since 2010?A.Patients with primary and non-primary sclerosing cholangitis (PSC) are included in these guidelines for the diagnosis and management of cholangiocarcinoma.B.Define "related stricture" as any biliary or hepatic duct stricture accompanied by the signs or symptoms of obstructive cholestasis and/or bacterial cholangitis.C.Patients who have had an inconclusive report from MRI and cholangiopancreatography should be reexamined by high-quality MRI/cholangiopancreatography for diagnostic purposes. Endoscopic retrograde cholangiopancreatography should be avoided for the diagnosis of PSC.D. Patients with PSC and unknown inflammatory bowel disease (IBD) should undergo diagnostic colonoscopic histological sampling, with follow-up examination every five years until IBD is detected.E. PSC patients with IBD should begin colon cancer monitoring at 15 years of age.F. Individual incidence rates should be interpreted with caution when using the new clinical risk tool for PSC for risk stratification.G. All patients with PSC should be considered for clinical trials; however, if ursodeoxycholic acid (13-23 mg/kg/day) is well tolerated and after 12 months of treatment, alkaline phosphatase (γ- Glutamyltransferase in children) and/or symptoms are significantly improved, it can be considered to continue to be used.H. Endoscopic retrograde cholangiopancreatography with cholangiocytology brushing and fluorescence in situ hybridization analysis should be performed on all patients suspected of having hilar or distal cholangiocarcinoma.I.Patients with PSC and recurrent cholangitis are now included in the new unified network organ sharing policy for the end-stage liver disease model standard.J. Liver transplantation is recommended after neoadjuvant therapy for patients with unresectable hilar cholangiocarcinoma with diameter < 3 cm or combined with PSC and no intrahepatic (extrahepatic) metastases.
Child
;
Humans
;
Cholangitis, Sclerosing/diagnosis*
;
Constriction, Pathologic/complications*
;
In Situ Hybridization, Fluorescence
;
Cholangiocarcinoma/therapy*
;
Liver Diseases/complications*
;
Cholestasis
;
Inflammatory Bowel Diseases/therapy*
;
Bile Ducts, Intrahepatic/pathology*
;
Bile Duct Neoplasms/therapy*
10.A Case of IgG4 Associated Sclerosing Cholangitis without Clinical Manifestations of Autoimmune Pancreatitis.
Song Wook CHUN ; Ja Sung CHOI ; Beo Deul KANG ; Yu Jin KIM ; Ki Jun HAN ; Hyeon Geun CHO ; Hwa Eun OH ; Jae Hee CHO
The Korean Journal of Gastroenterology 2013;62(1):69-74
IgG4-related systemic diseases are characterized by a diffuse or mass forming inflammatory reaction rich in lymphocytes and IgG4-positive plasma cells (lymphoplasmacytic infiltration), fibrosclerosis of variable organs and obliterative phlebitis. They usually involve various organs including the pancreas, bile duct, gallbladder, salivary gland, retroperitoneum, kidney, lung, and prostate. However, most of them are accompanied by autoimmune pancreatitis, and good response to steroid treatment is one of the hallmarks of this disease. We report a case of an 67-year-old man with IgG4 associated sclerosing cholangitis, who was diagnosed by endoscopic retrograde cholangiopancreatography and successfully treated with steroid therapy.
Aged
;
Anti-Inflammatory Agents/therapeutic use
;
Autoimmune Diseases/complications/diagnosis
;
Bile Ducts, Intrahepatic/pathology/ultrasonography
;
Cholangiopancreatography, Endoscopic Retrograde
;
Cholangitis, Sclerosing/complications/*diagnosis/drug therapy
;
Common Bile Duct/pathology/ultrasonography
;
Humans
;
Immunoglobulin G/*blood
;
Immunohistochemistry
;
Male
;
Pancreatitis/complications/diagnosis
;
Prednisolone/therapeutic use
;
Tomography, X-Ray Computed